Rani Therapeutics Holdings (RANI) Revenue (2020 - 2026)

Rani Therapeutics Holdings' Revenue history runs 5 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• On a quarterly basis, Revenue rose 893.02% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 164.08% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 58.85% from the prior year.
• Revenue rose to $1.7 million in Q1 2026 per RANI's latest filing, from $1.5 million in the prior quarter.
• Across five years, Revenue topped out at $1.7 million in Q1 2026 and bottomed at $172000.0 in Q1 2025.
• The 3-year median for Revenue is $1.2 million (2024), against an average of $1.1 million.
• Across the five-year window, Revenue soared 42.12% in 2025 and surged 893.02% in 2026, its largest moves.
• Year by year, Revenue stood at $1.0 million in 2024, then surged by 42.12% to $1.5 million in 2025, then rose by 16.91% to $1.7 million in 2026.
• Per Business Quant, the three latest RANI Revenue figures stand at $1.7 million (Q1 2026), $1.5 million (Q4 2025), and $172000.0 (Q1 2025).